STAT

OCTOBER 6, 2022

Meanwhile, here is the latest menu of tidbits to help you on your own journey, which we hope is pleasant and productive.  Even a drug-price watchdog, the Institute for Clinical and Economic Review, deemed the $2.8 And yes, this is made available by the same folks who operate the distillery. Please feel free to join us.

98

98

pharmaphorum

OCTOBER 18, 2022

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

Communication 52

Communication 52

European Pharmaceutical Review

MAY 22, 2023

A review by Swedish researchers has identified the benefits of smart contracts on blockchain platforms in the pharmaceutical supply chain and its role in combating counterfeit drugs. The review stated that therapeutic innovation has resulted in the production of expensive drugs to treat rare diseases, which need to be available on time.

87

87

pharmaphorum

OCTOBER 3, 2022

The third ALS treatment to be given FDA approval, following Mitsubishi Tanabe’s Radicava ($170,000 per year) and generic drug riluzole – Relyvrio is priced at around $12,500 per 28-day prescription. Currently, the ALS drug is priced about five times higher than the top of a value-based range. ALS affects over 30,000 people in the US.

Insurance 52

Insurance FDA 52

pharmaphorum

AUGUST 21, 2022

In this product, bupropion is designed to increase levels of dextromethorphan in the blood and extend its half-life. However, it has a broader label as unlike J&J’s drug it is indicated for use in previously-untreated MDD. The post Axsome bounces back as FDA clears depression drug appeared first on.

FDA 98

FDA Labelling 98

pharmaphorum

NOVEMBER 27, 2022

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products. Automation can be such a solution. Reducing capacity issues. Cutting down on safety stock.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

pharmaphorum

APRIL 26, 2021

The initiative was supported by grants from UCB and Pfizer and provided health information in the form of immersive experiences aimed at patients prescribed biologic drugs to treat the disease. The company halted development before it eventually sold its digital health unit back to Eric Careel, co-founder of Withings, the following year.

Hospitals 122

Hospitals 122

The Checkup by Singlecare

AUGUST 31, 2023

| How to get Mounjaro without insurance Mounjaro (tirzepatide) is a brand-name prescription drug FDA-approved to control blood sugar levels in people with Type 2 diabetes. Injected once per week, tirzepatide increases insulin production, reduces appetite, and causes weight loss. Mounjaro can only be purchased at a premium price.

Insurance 98

Insurance Compounding Insurance Coverage Labelling 98

pharmaphorum

NOVEMBER 19, 2021

The cost-effectiveness agency had turned down Evrysdi (risdiplam) in draft guidance published in June, saying it was too expensive, but after negotiations with Roche has reached a deal that will make the drug available to around 1,500 people in England. million price tag make it is the most expensive treatment ever approved for NHS funding.

98

98

pharmaphorum

APRIL 20, 2021

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator. . The Scottish Medicines Consortium is expected to publish its final advice on the drug later this year. billion by 2028.

Hospitals 111

Hospitals Documentation 111

pharmaphorum

JANUARY 11, 2021

US biotech bluebird bio has announced plans to split into two this year, with a separate oncology business spinning off as the company prepares to bring its products to market. million price tag. Meanwhile the as-yet unnamed oncology company will spin off under the leadership of bluebird’s current chief executive Nick Leschly.

FDA 66

FDA 66

pharmaphorum

NOVEMBER 19, 2020

Novartis/Genentech’s eye drug Lucentis could be the next big blockbuster to face competition from cheaper biosimilars after its US patent expired this year – and Samsung Bioepis and Biogen are closing in after the FDA accepted a filing for their cut-price rival.

FDA 64

FDA Labelling 64

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Communication 97

Communication Insurance Packaging Pharmaceutical Companies 97

European Pharmaceutical Review

AUGUST 24, 2022

ANTIBODY-DRUG conjugates (ADCs) are therapeutic molecules designed as highly targeted medicines with the promise of changing the way we treat cancer and other diseases. generation products from fully delivering on their initial promise. Consequently the market dynamics were slow, with just three approved ADC drugs until 2017.

Compounding 79

Compounding Pharmaceutical Companies Pharmaceutical Companies 79

The Checkup by Singlecare

DECEMBER 5, 2023

Ozempic became one of the most talked about drugs in 2023. The #ozempic tag on TikTok has amassed over 1 billion views to date. Although weight loss is a side effect of Ozempic, it isn’t approved as a weight loss drug. Food and Drug Administration (FDA) recently approved Zepbound , a new version of Mounjaro, for weight loss.

Insurance 105

Insurance Prescription Filling FDA Dosage 105

Pharmaceutical Technology

JULY 14, 2022

The commercial investment required to research and develop an innovative drug, prove its safety and efficacy, and bring it to market is staggering. Most famously, the US passed its Orphan Drug Act in 1983, providing innovators with financial motivation to develop orphan drugs and meet the needs of these forgotten patients.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Hospitals 59

pharmaphorum

SEPTEMBER 15, 2020

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.

Communication 130

Communication Documentation Labelling Vaccines 130

pharmaphorum

OCTOBER 29, 2021

Gilead’s Trop-2 targeting antibody-drug conjugate Trodelvy (sacituzumab govitecan) will be paired with Merck’s PD-1 inhibitor Keytruda (pembrolizumab) in a new phase 3 trial in previously-untreated subjects with locally advanced or metastatic TNBC. While its headline revenue of $7.4

Chemotherapy 52

Chemotherapy FDA 52

pharmaphorum

JANUARY 11, 2022

It is well-established for conventional drugs and medical devices but has only recently started to be used for DTx. The post Blue Note leukaemia DTx gets FDA breakthrough tag appeared first on. Breakthrough designations can speed up the development of new therapies, making them available to patients sooner.

FDA 64

FDA Chemotherapy Hospitals 64

pharmaphorum

DECEMBER 2, 2020

The company’s first product, a palatable anti-parasitic drug, made to taste like toffee, united Pfizer’s skills as a chemist with Erhart’s training as a confectioner. The “first industrial war” involved drug producers as much as weapons manufacturers. It was a success, and set the pattern for the company’s future development.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

pharmaphorum

JANUARY 21, 2022

“It has become clear that the medicines of the 20 th century, the so-called blockbuster era, are gradually being replaced by drugs designed for smaller groups, specific indication, and even for individual patients,” said Jo De C**k, CEO of Belgium’s National Institute for Health and Disability Insurance.

Insurance 52

Insurance Vaccines 52

Pharmaceutical Technology

FEBRUARY 22, 2023

The legal dispute is centered around rival cholesterol-lowering drugs produced by the two companies, which were approved in the summer of 2015. Both drugs are monoclonal antibodies that inhibit the protein PCSK9. Both drugs come with a high price tag. But in this case, Amgen has a fully finished product, he adds.

FDA 104

FDA 104

The Checkup by Singlecare

SEPTEMBER 7, 2023

Fortunately, drug therapy for diabetes has come a long way. This class of diabetes drugs has been linked to decreasing appetite, and because of that, patients taking incretin mimetics can lead to weight loss. Some drugs in this class are FDA-approved to aid in weight loss and management.

Insurance 52

Insurance Insurance Coverage FDA Dosage 52

pharmaphorum

JUNE 2, 2022

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any. Evaluate Pharma’s recent Orphan Drug Report subtitled its overview of the market ‘Niche no longer.’ It is estimated that between 3.5

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 2, 2021

NICE has rejected routine NHS funding for Roche’s Evrysdi (risdiplam) for spinal muscular atrophy drug in draft guidance, a decision which doesn’t come as a surprise to patient association SMA UK. Comments can be submitted until 23 June. — Spinal Muscular Atrophy UK (@SMA_UK_) June 2, 2021.

Documentation 52

Documentation Communication 52

The Checkup by Singlecare

NOVEMBER 2, 2023

These drugs mimic GLP-1, a hormone responsible for regulating appetite and food intake, leading to weight loss and improved control of blood sugar levels in people with Type 2 diabetes. These are the benefits of GLP-1 drugs , beyond blood sugar control. Rising demand for GLP-1 drugs: Why are they so popular?

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

Pharmaceutical Technology

APRIL 5, 2023

More than a decade after the first patient was treated with a CAR-T therapy, six therapies relying on the same principles have been approved by the US Food and Drug Administration (FDA) and marketed to thousands of patients. With blood cancers, you inject the product, and the cells are there, and the target is there.

FDA 59

FDA Immunization 59

The Checkup by Singlecare

JANUARY 15, 2023

The drug is an imperfect solution to a complex and frustrating condition. We will delve into that list, covering the different categories and drugs and calling attention to the most common picks. It was just approved in 2021 by the Food and Drug Administration. The drug provides galantamine in a once-daily pill.

Dosage 52

Dosage FDA Insurance 52

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

Labelling 105

Labelling Data Entry Communication FDA 105

The Checkup by Singlecare

MARCH 21, 2023

Opioids are prescription drug painkillers that are typically reserved for certain types of moderate to severe and sometimes chronic pain , and rarely for acute pain that is unresponsive to non-opioid medications like non-steroidal anti-inflammatory drugs ( NSAIDs ), Tylenol ( acetaminophen ), and certain antidepressants or anti-seizure medications.

Dosage 52

Dosage Controlled Substances Labelling Packaging 52

The Checkup by Singlecare

JANUARY 25, 2023

1 in 5 treat sunburn with an aloe vera product with a pain reliever, which is not recommended. According to the Food and Drug Administration (FDA) , one popular misconception surrounding SPF relates to the time of solar exposure. Less than half (46%) know the minimum recommended level of SPF is 30. 69% use sunscreen when outside.

Documentation 52

Documentation Insurance FDA 52

The FDA Law Blog

JUNE 27, 2023

Valentine Named Top Lawyer Under 40; Only Food and Drug Lawyer Selected Hyman, Phelps & McNamara, P.C. (HP&M) James was only one of five life sciences attorneys selected and the only food and drug lawyer to make the list. HP&M’s James E. Valentine , as a 2023 Rising Star. HP&M’s Kurt R.

FDA 81

FDA 81

Pharmaceutical Technology

JUNE 21, 2023

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. It is eligible for up to $1.6bn based on future milestones, as well as royalties amounting to more than 20% of net product sales.

FDA 98

FDA 98

Roots Analysis

SEPTEMBER 13, 2023

These molecules can be conjugated with various modalities, such as haptens, enzymes, isotopes, fluorescent tags, carrier proteins, polymers, particle conjugates and photoreactive molecules. Moreover, it provides a better understanding of the disposition of the drug and its role in causing organ toxicity.

Labelling 40

Labelling 40

Viseven

SEPTEMBER 14, 2023

The procurement cycle presupposes all decisions related to selecting suppliers and monitoring drug delivery and distribution. It typically falls into the following steps: Reviewing drug selections. Determining drug quantities. Receiving and checking drugs. Aligning needs with the budget. Selecting a procurement method.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmacy Procurement 52

pharmaphorum

FEBRUARY 26, 2021

Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is a strong pharmaceutical backbone that has emerged over the company’s long and varied history. It was incorporated as a separate company in 1949 so as to expand and diversify the J&J product line.

Vaccines 126

Vaccines Labelling Communication 126

pharmaphorum

AUGUST 26, 2022

BioMarin will no doubt have an eye on the earlier experience of bluebird bio, which secured EU approval for rare disease gene therapy Zynteglo (betibeglogene autotemcel) in 2019 for beta thalassaemia with a price tag of around €1.6 million spread over five years.

FDA 111

FDA 111